Navigation Links
Whistleblower's Attorney Says Pfizer's Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
Date:10/16/2009

WASHINGTON, Oct. 16 /PRNewswire/ -- Pfizer Inc., through a wholly owned subsidiary, is expected to plead guilty to a felony today in federal district court in Boston as part of a plea agreement that includes a record-breaking $1.3 billion criminal fine for the illegal marketing of the painkiller Bextra for unsafe and unapproved uses.

"This case exposed the total disregard a pharmaceutical company had for patients' lives by putting profits above all else," said Erika A. Kelton, a Washington, DC, attorney with Phillips & Cohen LLP, which represented the whistleblower who exposed Pfizer's "off-label" marketing of Bextra. "Pfizer created a corporate culture that encouraged and rewarded those who ignored federal safety laws to boost sales. It took an insider to bring these violations to light and dedicated government officials to stop them."

The federal government lays out details of Pfizer's sales and marketing tactics and strategy for Bextra in a sentencing memorandum, which is posted at http://www.phillipsandcohen.com/CM/NewsSettlements/U.S.Sentencing%20Memo%20re%20Pfizer%20(00015260).PDF

Pfizer's plea agreement was announced Sept. 2 as part of a record $2.3 billion settlement with the federal government, but it has to be approved by the court. In addition to the $1.3 billion criminal fine, Pfizer paid $502 million to the federal government to settle the whistleblower lawsuit brought by Phillips & Cohen that first revealed Pfizer's off-label marketing of Bextra. The remainder of the settlement covered five other "qui tam" lawsuits involving different drugs.

It was the largest criminal fine of any kind imposed in the U.S., the largest healthcare fraud settlement and the largest ever civil fraud settlement against a pharmaceutical company.

"The unprecedented size of the fine certainly shows the government is ratcheting up enforcement involving prescription drugs to protect patients and the Medicare program," Kelton said. "This is great news for whistleblowers, the public and the U.S. Treasury."

Kelton noted that today's outcome was possible only through the work of dedicated and talented government attorneys and staff, in particular Assistant U.S. Attorney Sara Bloom and Assistant U.S. Attorney Susan Poswistilo, both with the U.S. Attorney's office in Boston; Justice Department Trial Attorney Sanjay Bhambhani; and the National Medicaid Fraud Control Units team, headed by Massachusetts Assistant Attorney General Robert Patten.

About Phillips & Cohen LLP

Phillips & Cohen LLP is the nation's most successful law firm representing whistleblowers. "Qui tam" lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 billion. The firm's attorneys are regularly recognized for their successful work on whistleblower cases with inclusion on such select lists as the Top 10 "Winning Attorneys" in the U.S., the "100 Most Influential Lawyers" and the National Law Journal's "Hot List" of plaintiffs' law firms, most recently for 2009.

SOURCE Phillips & Cohen LLP


'/>"/>
SOURCE Phillips & Cohen LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine
4. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
5. University of Redlands Student Cody Unser Documentary Run to Start Today in L.A.
6. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
7. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
8. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
9. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
10. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
11. TCP Innovations Opens First US Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016   Click here ... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... a definitive agreement to acquire Valley Campus Pharmacy, ... ("TNH"), a leading specialty pharmacy that provides individualized ... California . In 2015, TNH generated approximately ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... , April 28, 2016 ... consumer insights on healthcare, announced today that it has ... report Cool Vendor in Life Sciences, 2016, ... 15, 2016.  The report focuses on life-science- oriented analytics, ... insight from patients and doctors, confirm medication ingestion, and ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... Dr. Trevor Gardner, President of ... signed a multifaceted agreement which will allow for the research and development of ... Natural and Applied Sciences, Allied Health and Nursing will work together to develop ...
(Date:4/30/2016)... Santa Rosa, CA (PRWEB) , ... April 30, 2016 , ... “Aging well is a challenge for all of us, ... says NCMA’s Dr. Parul T. Kohli . “Research is showing more and more that ... the risk of disease and disability as we age.” Top priorities Dr. Kohli’s recommends for her ...
(Date:4/29/2016)... ... April 30, 2016 , ... World ... the Pick Up Springboard, an automotive invention that improves the storage features of ... worth $162 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
(Date:4/29/2016)... Fl (PRWEB) , ... April 29, 2016 , ... ... recently notified by the Accreditation Council for Graduate Medical Education (ACGME) that it ... , This is the first accreditation of three residency programs that Memorial is ...
Breaking Medicine News(10 mins):